Table 2.
Assessment of pulse and full blood count at baseline and day 42
| Variable | Rifaximin group baseline | Rifaximin group day 42 | P value | Non-rifaximin group baseline | Non-rifaximin group day 42 | P |
|---|---|---|---|---|---|---|
| Pulse rate (beats/minute) | 76 (66, 82) | 65 (60, 72) | < 0.01 | 70 (64, 76) | 66 (62, 70) | 0.07 |
| Hb (g/dL) | 7.5 (6.2, 11.3) | 11.5 (9.0,13.0) | 0.01 | 9.2 (6.6, 11.0) | 10.3 (8.5, 12.4) | 0.03 |
| MCV (fl) | 80 (67, 87) | 76 (66, 86) | 0.09 | 79.0 (70.2, 82.7 | 79.4 (68.1, 91.9) | 0.82 |
| WCC (×109/L) | 2.7 (1.6, 3.5) | 2.0 (1.6, 2.5) | 0.04 | 1.8 (1.6, 3.0) | 2.2 (1.6, 3.5) | 0.67 |
| RBC (×1012/L) | 3.4 (2.7, 4.3) | 4.5 (4.0, 4.9) | 0.01 | 3.6 (3.0, 4.4) | 4.3 (3.6, 5.2) | 0.06 |
| PLT (×109/L) | 49 (31, 78) | 42 (28, 72) | 0.61 | 44 (24, 64) | 38 (25, 52) | 0.74 |
Hb = hemoglobin; MCV = mean cell volume; PLT = platelets; RBC = red blood cells; WCC = white cell count.
All parameters are represented as median with interquartile range in parenthesis.